Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Familial tumoral calcinosis with hyperphosphatemia is heterogeneous and associated with mutations in GALNT3 or FGF-23].

Annales de dermatologie et de venereologie - 1 Apr 2006

Dereure O

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcinosis
Share to Fibroblast Growth Factor-23
Share to Fibroblast Growth Factors
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to N-Acetylgalactosaminyltransferases

Share to Neoplasm Proteins

Share to Polypeptide N-acetylgalactosaminyltransferase

Share to Skin Neoplasms

Source

Identifiers

PMID: 16733465
DOI: 10.1016/s0151-9638(06)70928-0

Genes

GALNT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Familial tumoral calcinosis with hyperphosphatemia is heterogeneous and associated with mutations in GALNT3 or FGF-23].PMID 16733465Read ↗

Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindredSemantic proximity Read ↗

Hyperphosphatemic familial tumoral calcinosis caused by a novel variant in the GALNT3 gene.Semantic proximity Read ↗

Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations.Semantic proximity Read ↗

Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis.Semantic proximity Read ↗

Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?Semantic proximity Read ↗

Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.Semantic proximity Read ↗

Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature.Semantic proximity Read ↗

A case of familial tumoral calcinosis/hyperostosis–hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic featuresSemantic proximity Read ↗

Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disordersSemantic proximity Read ↗

Clinical and Functional Characterization of Novel GALNT3 Mutations in a Chinese Child with Hyperphosphatemic Familial Tumoral Calcinosis.Semantic proximity Read ↗

Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action.Semantic proximity Read ↗

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.